CBG shows genuine anti-inflammatory activity in lab dishes and animal models. What it does not show, at least not yet, is proof from a large human trial that it lowers inflammation in people. That gap matters, because plenty of CBG products on shelves carry claims the science does not back.
CBG Dosage for Maximum Benefits: A Comprehensive Guide
So if you are dealing with joint pain, gut flares, or skin irritation and wondering whether cannabigerol is worth your money, here is the honest version.
How Does CBG Work in the Body? A Guide to Its Targets
The short answer
CBG is a non-intoxicating cannabinoid with a reasonable biological case for fighting inflammation. The evidence is early. Mouse colitis studies and cell cultures look promising. Human trials are basically absent. I would treat CBG as a low-risk experiment, not a treatment, and I would not stop a prescribed anti-inflammatory drug to try it.
What CBG is
Cannabigerol is one of roughly 100 cannabinoids found in cannabis. It starts life as CBGA, the acidic mother cannabinoid that enzymes convert into THC, CBD, and other compounds as the plant matures. Most dried flower finishes with well under 1% CBG, which is why CBG-dominant cultivars exist and why most CBG products are made by extracting hemp.
CBG Benefits for Glaucoma: What the Evidence Shows
CBG does not get you high. It binds weakly at CB1 and CB2 receptors, and researchers have identified several other targets, including alpha-2 adrenergic receptors and the 5-HT1A receptor. Those targets are why it gets mentioned alongside pain, gut issues, and inflammation.
What the research actually shows
The most cited work is a 2013 mouse study on inflammatory bowel disease. Researchers gave CBG to mice with chemically induced colitis and saw less colon damage, lower nitric oxide, fewer reactive oxygen species, and reduced macrophage infiltration. That is a real signal. It is also a mouse.
Cell studies point the same direction. CBG has been shown to tamp down inflammatory cytokine production in several cell models, and a 2021 pharmacology review lays out its CB2 activity and other immune-relevant pathways.
Two caveats I always raise. First, doses in animal studies are often far higher than what a person takes. Second, lowering a marker like TNF-alpha in a dish is not the same as lowering a person's joint swelling or CRP.
CBG vs CBD for inflammation
- CBD has more human research overall, though most of it covers epilepsy, anxiety, and skin rather than systemic inflammation.
- CBD's strongest human anti-inflammatory data is topical, in acne and select skin conditions.
- CBG has a compelling in-vitro receptor story in some labs and much weaker human data.
- Products that combine them lean on entourage effect marketing. Whole-plant extracts show some advantage over isolates in a few studies, but that is not proof a specific CBG-plus-CBD tincture works better than either alone.
Dosing, if you decide to try it
There is no established dose. Human pharmacokinetic data for isolated CBG is thin. Anecdotal ranges run from about 5 to 25 mg per dose, with most people starting at 5 to 10 mg. Oral onset is usually 30 to 90 minutes. Topicals act faster where you apply them and do not do much systemically.
My rule: pick one product, hold the dose steady for a week or two, and write down what changes. Jumping doses every day tells you nothing about whether it helped.
Safety and drug interactions
Short-term studies describe CBG as well tolerated. Reported side effects are mild: dry mouth, drowsiness, upset stomach, appetite changes.
The interactions are the part people skip. Cannabinoids can affect cytochrome P450 enzymes, the same system that clears blood thinners, immunosuppressants, some seizure medications, and certain antidepressants. If you take any of those, talk to your pharmacist before adding CBG. Skip it if you are pregnant or breastfeeding, and keep it away from kids and pets.
US legal and shopping notes
Hemp-derived CBG with no more than 0.3% THC is federally legal under the 2018 Farm Bill. State rules differ, and a few states restrict cannabinoid products more tightly. The FDA has not approved CBG as a drug and has warned sellers over unproven health claims, so treat the word anti-inflammatory on a label as marketing.
What I look for: a batch-specific certificate of analysis from an accredited lab, potency numbers that match the label, and a contaminant panel covering pesticides, heavy metals, and residual solvents. If a brand will not show that, I move on.
Bottom line
CBG for inflammation is a plausible bet with weak human proof. It is not a replacement for a prescription anti-inflammatory, and no honest product should promise you that. Try it if you are curious, keep the dose simple, and judge it on your own results over a few weeks rather than on a label.